Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
Portfolio Pulse from Lisa Levin
U.S. stocks traded mostly lower with the Dow Jones falling over 100 points. Dick's Sporting Goods (DKS) reported worse-than-expected Q2 results and lowered FY23 guidance. Fulcrum Therapeutics (FULC), Fabrinet (FN), and ProMIS Neurosciences (PMN) saw their shares rise after positive news. Republic First Bancorp (FRBK) and Dragonfly Energy Holdings (DFLI) shares dropped due to negative news.
August 22, 2023 | 7:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dragonfly Energy Holdings shares dropped after the company reported downbeat Q2 results and issued a weak forecast for Q3.
The company's disappointing earnings and weak forecast are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Dick's Sporting Goods reported worse-than-expected Q2 results and lowered FY23 guidance.
The company's worse-than-expected earnings and lowered guidance are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Republic First Bancorp shares dropped after the Nasdaq notified the company that it will not be listed on the exchange due to non-filing of its Form 10-K Annual Report.
The Nasdaq's decision to delist the company due to non-filing of its Form 10-K Annual Report is negative news and is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Fabrinet shares rose after the company reported better-than-expected Q4 financial results and issued guidance.
The company's better-than-expected earnings and positive guidance are likely to boost the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Fulcrum Therapeutics shares rose after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
The FDA's decision to lift the clinical hold on FTX-6058 is positive news for the company and is likely to boost the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
ProMIS Neurosciences shares rose after the company announced a $20.4 million private placement financing.
The company's announcement of a significant private placement financing is likely to boost the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100